Back to results
US 2026/0062444 A1Published application
Modified peptide fragments of cav-1 protein and the use thereof in the treatment of fibrosis
AssigneeRein Therapeutics, Inc.
InventorsDale CHRISTENSEN, John J. KOLENG
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions comprising modified caveolin-1 (Cav-1) peptides. Further provided are methods of using the modified Cav-1 peptides for the treatment of lung infections or acute or chronic lung injury, particularly lung fibrosis.
Claims27
A method of treating or preventing fibrosis in a subject comprising administering to the subject an effective amount of a pharmaceutical composition comprising a peptide consisting of an amino acid sequence of Ac-aaEGKASFTTFTVTKGSaa-NH2 (SEQ ID NO:
- 8).
Dependencies are inferred from the claim text.